Metal-Based Therapeutics Target Cancer Drug Resistance in Oncology Review
A 2026 oncology review examines how metal-based therapeutics may counter cancer drug resistance through targeting, signaling disruption, and delivery strategies.
Therapeutics, diagnostics and evidence shaping cancer care.
Therapeutics, diagnostics and evidence shaping cancer care.